Skip to content

Clinical trials

Recruiting Phase 1/2 Lymphoma, Large B-Cell, Diffuse trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 1/2 Status: Recruiting Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20182
20191
20202
20214
20234
20246
20257
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting32

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC2
AVM Biotechnology Inc1
AvenCell Therapeutics, Inc.1
BeOne Medicines1
Cancer Research UK1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Curocell Inc.1
Dizal Pharmaceuticals1
Essen Biotech1
Genfleet Therapeutics (Shanghai) Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse32
Lymphoma, Non-Hodgkin12
Lymphoma, Follicular11
Lymphoma, Mantle-Cell9
Leukemia, Lymphocytic, Chronic, B-Cell8
Lymphoma7
Lymphoma, B-Cell7
Burkitt Lymphoma4
Lymphoma, B-Cell, Marginal Zone4
Leukemia3

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.